These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23616407)

  • 1. Cross-protective efficacy of recombinant transferrin-binding protein A of Haemophilus parasuis in guinea pigs.
    Huang X; Li Y; Fu Y; Ji Y; Lian K; Zheng H; Wei J; Cai X; Zhu Q
    Clin Vaccine Immunol; 2013 Jun; 20(6):912-9. PubMed ID: 23616407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.
    Frandoloso R; Martínez S; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Martínez-Fernández B; Gutiérrez-Martín CB
    Clin Vaccine Immunol; 2011 Jan; 18(1):50-8. PubMed ID: 20926701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights about functional and cross-reactive properties of antibodies generated against recombinant TbpBs of Haemophilus parasuis.
    Barasuol BM; Guizzo JA; Fegan JE; Martínez-Martínez S; Rodríguez-Ferri EF; Gutiérrez-Martín CB; Kreutz LC; Schryvers AB; Frandoloso R
    Sci Rep; 2017 Sep; 7(1):10377. PubMed ID: 28871190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.
    Hau SJ; Eberle KC; Brockmeier SL
    Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the recombinant proteins RlpB and VacJ as a vaccine for protection against Glaesserella parasuis in pigs.
    Hau SJ; Luan SL; Loving CL; Nicholson TL; Wang J; Peters SE; Seilly D; Weinert LA; Langford PR; Rycroft AN; Wren BW; Maskell DJ; Tucker AW; Brockmeier SL;
    BMC Vet Res; 2020 May; 16(1):167. PubMed ID: 32460764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice.
    Fu S; Zhang M; Ou J; Liu H; Tan C; Liu J; Chen H; Bei W
    Vaccine; 2012 Nov; 30(48):6839-44. PubMed ID: 23000128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of secreted proteins as novel antigenic vaccine candidates of Haemophilus parasuis serovar 5.
    Li M; Song S; Yang D; Li C; Li G
    Vaccine; 2015 Mar; 33(14):1695-701. PubMed ID: 25704800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and antigenic characterization of three recombinant proteins with potential for Glässer's disease prevention.
    Li M; Li C; Song S; Kang H; Yang D; Li G
    Vaccine; 2016 Apr; 34(19):2251-8. PubMed ID: 26993332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence, transmission, and heterologous protection of four isolates of Haemophilus parasuis.
    Brockmeier SL; Loving CL; Mullins MA; Register KB; Nicholson TL; Wiseman BS; Baker RB; Kehrli ME
    Clin Vaccine Immunol; 2013 Sep; 20(9):1466-72. PubMed ID: 23885030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vaccine based on a mutant transferrin binding protein B of Haemophilus parasuis induces a strong T-helper 2 response and bacterial clearance after experimental infection.
    Martínez-Martínez S; Frandoloso R; Rodríguez-Ferri EF; García-Iglesias MJ; Pérez-Martínez C; Álvarez-Estrada Á; Gutiérrez-Martín CB
    Vet Immunol Immunopathol; 2016 Oct; 179():18-25. PubMed ID: 27590421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of recombinant Haemophilus parasuis SH0165 putative outer membrane proteins.
    Fu S; Zhang M; Xu J; Ou J; Wang Y; Liu H; Liu J; Chen H; Bei W
    Vaccine; 2013 Jan; 31(2):347-53. PubMed ID: 23149270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a recombinant transferrin-binding protein A (TbpA) fragment from Haemophilus parasuis serovar 5.
    Martínez S; Frandoloso R; Rodríguez-Ferri EF; González-Zorn B; Gutiérrez-Martín CB
    FEMS Microbiol Lett; 2010 Jun; 307(2):142-50. PubMed ID: 20402790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic antibody response in colostrum-deprived pigs experimentally infected with Haemophilus parasuis.
    Martín de la Fuente AJ; Rodríguez-Ferri EF; Frandoloso R; Martínez S; Tejerina F; Gutiérrez-Martín CB
    Res Vet Sci; 2009 Apr; 86(2):248-53. PubMed ID: 18783805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-protection experiment in pigs vaccinated with Haemophilus parasuis serovars 2 and 5 bacterins, and evaluation of a bivalent vaccine under laboratory and field conditions.
    Takahashi K; Naga S; Yagihashi T; Ikehata T; Nakano Y; Senna K; Maruyama T; Murofushi J
    J Vet Med Sci; 2001 May; 63(5):487-91. PubMed ID: 11411491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble expression of OmpA from Haemophilus parasuis in Escherichia coli and its protective effects in the mouse model of infection.
    Ahn J; Hong M; Yoo S; Lee E; Won H; Yoon I; Jung JK; Lee H
    J Microbiol Biotechnol; 2012 Sep; 22(9):1307-9. PubMed ID: 22814508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omp16-based vaccine encapsulated by alginate-chitosan microspheres provides significant protection against Haemophilus parasuis in mice.
    Zheng X; Yang X; Li X; Qiu GH; Dai A; Huang Q; Huang C; Guo X
    Vaccine; 2017 Mar; 35(10):1417-1423. PubMed ID: 28187951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic characterization of vaccines based on Haemophilus parasuis Nagasaki strain, OmpP2, OmpP5 and OmpD15, in colostrum-deprived pigs experimentally challenged with the same strain.
    Álvarez-Estrada Á; Martínez-Martínez S; Martín CG; García-Iglesias MJ; Pérez-Martínez C; Yubero-Delgado S; Guizzo JA; Frandoloso R; Rodríguez-Ferri EF
    Res Vet Sci; 2018 Aug; 119():292-301. PubMed ID: 30081339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First comparison of adjuvant for trivalent inactivated Haemophilus parasuis serovars 4, 5 and 12 vaccines against Glässer's disease.
    Xue Q; Zhao Z; Liu H; Chen K; Xue Y; Wang L
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):153-8. PubMed ID: 26672914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomics of Haemophilus (Glässerella) parasuis serovar 5 subjected to culture conditions partially mimetic to natural infection for the search of new vaccine antigens.
    Álvarez-Estrada Á; Gutiérrez-Martín CB; Rodríguez-Ferri EF; Martínez-Martínez S
    BMC Vet Res; 2018 Nov; 14(1):326. PubMed ID: 30400794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute phase protein concentrations in colostrum-deprived pigs immunized with subunit and commercial vaccines against Glässer's disease.
    Martínez-Martínez S; Frandoloso R; Gutiérrez-Martín CB; Lampreave F; García-Iglesias MJ; Pérez-Martínez C; Rodríguez-Ferri EF
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):61-7. PubMed ID: 21816489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.